Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Biotechnology VC Funds in Israel

Last updated: Apr 2024 A list of 50 VC funds that invest in Biotechnology startups based in Israel. We rank investors based on the number of investments they made in Biotechnology companies from Israel. We update this investor list every month.

Top 50 Biotechnology VC Funds in Israel

Investor	Biotechnology Israel investments
Trendlines Group	18
Pontifax	18
Israel Innovation Authority	9
OurCrowd	9
Docor International Management	7
OrbiMed	7
aMoon Fund	6
HBL Hadasit Bio Holdings	6
Arkin Holdings	6
Johnson & Johnson Robotics and Digital Solutions	4
Takeda Ventures	4
Clal Biotechnology Industries	4
Millenium Food-Tech	4
ZORA Ventures	4
Integra Holdings	4
Accelmed	4
S2G Ventures	4
iAngels	4
Welltech Ventures	3
Ziegler Meditech Equity Partners	3
Pitango VC	3
Consensus Business Group	3
Sapir Venture Partners	3
Office of the Chief Scientist	3
Binder & Partners Ventures	3
Neo Ventures	3
Triventures	3
SciSparc	3
FutuRx	3
EIT Food	2
Tal Ventures	2
Good Seed Ventures	2
GlenRock Israel	2
Cancer Focus Fund	2
Elron Ventures	2
Aurum Ventures MKI	2
HealthpointCapital	2
NFX Bio	2
Minrav	2
Jerusalem Global Ventures	2
The Chartered Group	2
DSM Venturing	2
RMGP Biopharma Investment Fund	2
Nevateam Partners	2
Tyson Ventures	2
VentureIsrael	2
SCP Vitalife Partners	2
Genesis Park	2
BRM Capital	2
Chartered Opus	2

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Investment focus

Health Care, Biotechnology, Medical Device
Seed, Funding Round, Series A
Israel, Singapore, United Kingdom

Portfolio highlights

Insectta — Insectta was founded in 2017 and produces materials from insects which can be applied across industries such as agrifood, pharmaceutical and electronics.
Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
ViAqua Therapeutics — ViAqua is developing the first orally administered treatment in aquaculture to stop diseases from developing and to prevent viral epidemics.

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Israel, France

Portfolio highlights

Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
AgomAb Therapeutics — AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

The Israeli innovation agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Investment focus

Health Care, Biotechnology, Medical Device
Grant, Seed, Pre-Seed
Israel, United States, Mali

Portfolio highlights

BloomX — Helping nature do its magic with the power of technology
MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
NurExone Biologic — New approach to Spinal Cord Injury treatment based on view that intranasal exosome administration offers alternative to cell transplantation

Access exclusive venture capital angel investment deals in pre-vetted startup companies. Create your free OurCrowd investor account today!

Investment focus

Software, Artificial Intelligence, Machine Learning
Series B, Series A, Seed
Israel, United States, Canada

Portfolio highlights

Cyabra — We break down social media so you can understand narratives, detect authenticity and reach true audiences.
SeeTree — SeeTree offers you complete transparency into the health and production of each of your trees by leveraging the most powerful innovations available.
blackshark.ai — Blackshark.ai hi-frequency mapping provides cutting-edge geospatial AI and 3D visualization for object detection, training and simulation.

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Funding Round, Series C, Series A
Israel, United States

Portfolio highlights

Check-Cap — The first and only patient-friendly preparation-free test to detect polyps before they may transform into cancer
Ocon Healthcare — OCON Healthcare innovates, develops, manufactures, and commercializes cutting-edge women’s health products based on our patented IUB™ (Intra Uterine Ball) proprietary platform. The IUB™, made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.In addition to our flagshipproduct, the IUB™ Ballerine®, OCON healthcare is developing an innovative pipeline of products utilizing the IUB™ frame for indications such as abnormal uterine bleeding (AUB), heavy menstrual bleeding (HMS), myomas/fibroids, and infertility.
Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
United States, China, Israel

Portfolio highlights

Avalo Therapeutics — Avalo Therapeutics is a clinical-stage biopharmaceutical company that employs a precision medicine approach to discover, develop, and commercialize highly targeted therapeutics in areas of significant unmet clinical need.
Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
Alterome Therapeutics — Transforming the lives of cancer patients, one alteration at a time. Our Mission is to discover precise therapies and inspire hope for individuals affected by cancer.

aMoon is a leading healthtech & life sciences venture capital firm.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Funding Round
United States, Israel, Switzerland

Portfolio highlights

Eleos Health — Automate documentation, alleviate provider burnout, and elevate care quality with the CareOps Automation platform from Eleos Health.
Better Life Partners — The Better Life Partners team helps people achieve healthier lives filled with purpose. We offer community support as well as virtual care.
Ibex Medical Analytics — Ibex Medical Analytics develops AI-driven clinical decision support tools that help pathologists deliver more efficient, metric-driven, objective and accurate diagnosis. It combines AI, data science, image analysis and machine learning technologies and applies them to cancer diagnostics in digital pathology.

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Investment focus

Biotechnology, Medical, Health Care
Funding Round, Series A, Series B
Israel

Portfolio highlights

ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.

Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcareinvestments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Seed, Funding Round
Israel, United States, Switzerland

Portfolio highlights

Percepto — Percepto is a developer of autonomous drone technology for inspection and surveillance.Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier tomaking them a must-have platform is the ability of drones to perform tasks autonomously.The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data.Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.
MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.

Healthcare innovation wherever it originates.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
United States, Israel, United Kingdom

Portfolio highlights

Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
Artera — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
ONL Therapeutics — ONL Therapeutics develops innovative therapeutics to protect and improve the vision of patients with a range of retinal diseases and conditions.

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Funding Round
United States, United Kingdom, Israel

Portfolio highlights

Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)

Investment focus

Biotechnology, Health Care, Medical
Series A, Funding Round, Series B
Israel, United States

Portfolio highlights

Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.

Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.

Investment focus

Food and Beverage, Manufacturing, Agriculture
Seed, Series A, Convertible Note
Israel

Portfolio highlights

Tipa — Tipa has developed breakthrough 100% biodegradable and compostable flexible packaging solutions for food and beverages. Imitating nature’s and just like an orange peel, their packaging solutions bring a new generation of packaging that easily biodegrade post-consumption and reduce dramatically their impact on the environment.Ranging from simpleone-ply films to complex multi-layer products, their packaging solutions offer a combination of superior properties in almost every aspect including high yield, flexibility, transparency, impact strength, and barrier properties.
Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
Supersmart — Supersmart is the world's leading loss-prevention solution for self-scan transactions. Supersmart uses its proprietary machine-learning, AI algorithm to validate all self-scanning transactions in physical stores. Our solution enables retailers to confidently provide self-scanning options to their customers, enhancing customer experiencewithout sacrificing potential loss.The Israel-based company was founded in 2014 by Yair Cleper and Amir Ayalon.

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

Investment focus

Health Care, Biotechnology, Internet
Seed, Series A, Convertible Note
Israel, United States, United Kingdom

Portfolio highlights

BiotaX — Microbiome Genomic Analysis Cloud Platform | Biotax.co
EyeControl — EyeControl is a medical technology company specializing in innovative communication solutions. We implement advanced AI-technologies to bridge information barriers, facilitating better care and decision-making in healthcare environments.
Forsea Foods — Forsea Foods develops cell-cultured seafood through the use of patented organoid technology which allows them to bypass the scaffolding stage of cultivated meat production.

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Investment focus

Biotechnology, Pharmaceutical, Life Science
Seed, Series B, Series F
Israel

Portfolio highlights

BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria

Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.

Investment focus

Health Care, Medical Device, Medical
Funding Round, Series A, Series D
Israel, United States

Portfolio highlights

Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
Minerva Surgical — Minerva Surgical develops minimally invasive devices to treat the root causes of Abnormal Uterine Bleeding.
Click Therapeutics — Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive datascience platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.

S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.

Investment focus

Food and Beverage, Agriculture, Biotechnology
Series A, Series B, Funding Round
United States, Canada, Israel

Portfolio highlights

Unseenlabs — Unseenlabs designs and develops a spectrum surveillance payload which is designed to detect and track non-cooperative vessels wherever they happen to be in the world.
Aquaconnect — Aquaconnect was founded in 2017 as a full-stack aquaculture technology venture to offer data-driven farm advisory solutions and market place solutions to Shrimp and Fish farmers. As a part of promoting sustainable farming practices in aquaculture ecosystem, we have launched an Artificial Intelligence farm advisor 'FarmMOJO' - a friendlyfarm companion. FarmMOJO's data intelligence improves farm productivity and connects farmers with aquaculture industry stakeholders under its market place. Aquaconnect works with about 3000 farmers in Indian states of Andhra, Tamilnadu, and Gujrat to improve their farm revenues through technology intervention.
Kuehnle Agrosystems — Kuehnle AgroSystems curates a unique set of algae originating from pristine waters and ecosystems of Hawaii, as well as tropical botanical accessions representing plants prized by Polynesian voyagers.

Invest in groundbreaking startups with iAngels. Discover cutting-edge technology and join a community of forward-thinking investors shaping the future of entrepreneurship.

Investment focus

Artificial Intelligence, Software, Financial Services
Seed, Series A, Funding Round
United States, Israel, United Kingdom

Portfolio highlights

Vyzer — One platform for investment tracking, financial planning, data-driven insights, document analysis & more! Ideal for diverse portfolios.
Guardz — Discover the platform that secures and insures small businesses using AI and a multilayered approach.
CoinScan — Fastest trading history in the industry for any ETH token along with seeing pending transactions. One-of-a-kind Airdrops and Holders distribution for quick analysis and much more.

Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.

Investment focus

mHealth, Health Care, Biotechnology
Seed, Funding Round, Pre-Seed
Israel, United States

Portfolio highlights

Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
AMKIRI — Amkiri has scientifically developed a Brand New product category for the beauty industry which combines the senses of smell and sight, and enables the complete freedom of multi-sensory self-expression.
Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.

Ziegler is a privately held investment bank, capital markets and proprietary investments firm.

Investment focus

Health Care, Biotechnology, Mobile
Series C, Series E, Series F
United States, Israel

Portfolio highlights

Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

Investment focus

Software, Health Care, Information Technology
Series A, Series B, Series C
Israel, United States, China

Portfolio highlights

Variantyx — Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditionalstep-wise, reiterative genetic testing.
Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Salvador Technologies — Salvador Technologies provides the world's fastest recovery from cyber-attacks and software/hardware malfunctions. Our innovative solution ensures the continuous operation of critical workstations and servers, eliminating downtime. Back to work in 30 seconds based on offline air-gapped sotrage.

Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.

Investment focus

Health Care, Medical Device, Biotechnology
Funding Round, Seed, Series B
Israel, United States, United Kingdom

Portfolio highlights

BioProtect — BioProtect Ltd. is an international medical device startup. It is primarily engaged in to the business of developing and commercializing biodegradable balloon spacers for the protection of normal tissue during cancer radiation therapy. The company's current focus in the growing radiotherapy spacers market, where its ProSpace balloon spacer (CEmarked) has shown superior efficacy and safety in protecting the rectum during radiation therapy for prostate cancer. The company's technology platform of biodegradable implantable balloons suits a wide range of applications for unmet clinical needs. BioProtect was founded in the year 2004 and headquartered in Israel, with subsidiaries in Germany and US.
Exero Medical — Exero Medical is a medical device manufacturing company. It develops a biodegradable wireless sensor for early detection of anastomotic leaks following GI Surgery. Its system is designed to prevent complications by warning physicians of a potential leak, enabling early intervention.The company was founded in 2018 and is headquartered in OrYehuda, Israel.
RepAir — RepAir develops a Direct Air Capture system based on a proprietary electrochemical cell technology that can capture CO2 from the air in gigaton scale. Powered solely by renewable energy, our system can be deployed at the site of carbon storage or utilizations, saving arable land and avoiding CO2 transport.

Early Stage VC

Investment focus

Software, Biotechnology, Machine Learning
Seed, Pre-Seed, Series A
Israel, United States, United Kingdom

Portfolio highlights

Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
DeepCure — Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.
Genetika+ — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.

The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.

Investment focus

Health Care, Biotechnology, Hardware
Seed
Israel

Portfolio highlights

LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
Immunovative Therapies — Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.

Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.

Investment focus

Software, Information Technology, Health Care
Seed, Pre-Seed, Series A
Israel, France, United States

Portfolio highlights

Rookout — Speed up the debugging process and accelerate your team's velocity with Rookout's live, remote debugging platform. Debug anything, anywhere. Effortlessly.
Lumen — Lumen is a device and app that measures your metabolism in a single breath and provides daily personalized nutrition based on your metabolic data. Through the device and app, you can achieve your fitness goals whether they be weight loss, performance optimization, or simply improving your metabolic health.As a company, we are a team ofscientists, researchers, engineers, and designers, aimed at improving the way people understand their metabolism. We believe that a healthy metabolism is a key to better health and that everyone can attain it with a little help from Lumen.At Lumen, we are all about teamwork, friendship, and family. Curious about joining? We are always looking for creative people who share our passion for health and fitness to join our team.
Blink Technologies — Blink creates the ultimate interaction between your eyes & the world around you with our eye tracking software & eye tracking technology.

Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.

Investment focus

Software, Artificial Intelligence, Aerospace
Seed, Funding Round, Series A
Israel, United Kingdom, Estonia

Portfolio highlights

EnduroSat — EnduroSat designs, builds and operates class-leading NanoSats for a range of commercial, exploration and science missions. We focus on inter-satellite connectivity and space data applications
Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.

Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.

Investment focus

Health Care, Medical Device, Medical
Funding Round, Series B, Seed
United States, Israel, Ireland

Portfolio highlights

FEMSelect — More than half of women over 50 are living with Pelvic Organ Prolapse. Learn about EnPlace, the minimally invasive approach to Pelvic Organ Prolapse.
Future Family — Our loans for IVF & egg freezing make it easy for you to get started quickly with fertility treatment. Learn more about our Fertility Financing & Loans today!
Brightside Health — Get anxiety and depression treatment online from licensed psychiatric providers and therapists. No need to wait, start a free consultation online today.

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.

Investment focus

Pharmaceutical, Cannabis, Biopharma
Funding Round, Corporate Round
Israel

Portfolio highlights

LaraPharm — LaraPharm Ltd. is a group of people joined together by the belief that active components found in the Cannabis plant can provide a real answer to hundreds of types of disease currently not addressed at all, or poorly addressed.
MitoCareX Bio — MitoCareX Bio is a biotechnology company that focuses on the discovery and development of drugs for cancers & other life-threatening diseases.

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Investment focus

Biotechnology, Life Science, Biopharma
Seed, Funding Round
Israel

Portfolio highlights

Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.

EIT Food is a European Knowledge and Innovation Community (KIC), which was set up to transform our food ecosystem. By connecting consumers with businesses, start-ups, researchers and students from around Europe, EIT Food supports innovative and economically sustainable initiatives which improve our health, our access to quality food, and our environment

Investment focus

Biotechnology, Food and Beverage, AgTech
Grant, Seed, Funding Round
The Netherlands, United Kingdom, Israel

Portfolio highlights

LenioBio — We are redefining biopharma manufacturing. At LenioBio we believe that every person deserves an equal chance to lead a healthy life.
3D Bio-Tissues — 3D Bio-Tissues (3DBT) is a biotech startup spun-out from Newcastle University in 2019. Our ambition is to produce bio-equivalent tissues for clinical and cellular agriculture. We apply novel bio-inspired manufacturing processes to generate complex structures.
BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.

TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.

Investment focus

Software, Artificial Intelligence, Machine Learning
Seed, Series A, Series B
Israel, United States, Cyprus

Portfolio highlights

Atly — Skip the hunt. Find the best restaurants, date spots, hiking trails and more through groups of people who share your interests.
Octup — Elevate your e-commerce business with our comprehensive E-commerce Operations Platform. Streamline processes, boost efficiency, and drive sales growth!
TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.

Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Series A, Pre-Seed
Germany, Israel, United States

Portfolio highlights

Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

Investment focus

Software, Cyber Security, Medical Device
Seed, Series B, Series A
Israel, United States

Portfolio highlights

Cylus — Cylus, the global leader in rail cybersecurity, helps rail, freight and metro companies avoid service disruption and safety incidents by detecting cyber-attacks in their signaling and control networks, wayside and onboard, before harm happens.
Karamba Security — Karamba Security's patented software detects and prevents cyberattacks on a wide variety of connected devices and systems, including automotive ECUs, Industry 4.0 controllers, enterprise edge devices, and IoT endpoints. Karamba's security solutions are embedded within devices and work automatically, without any need for customer operationand with negligible performance impact.
Quris — Quris Technologies is an artificial intelligence (AI) innovator disrupting the pharmaceutical arena.

Cancer Focus Fund is an investment firm that is dedicated to providing financial services to its clients. The company was founded by Ross Barrett.

Investment focus

Medical, Biotechnology, Health Care
Funding Round, Seed, Series A
Israel, United States

Portfolio highlights

ImmunoGenesis — We are rapidly translating the most cutting-edge discoveries from academic tumor immunology into drugs optimized for treating the majority of patients who have "cold" cancers refractory to currently available immunotherapy.
March Biosciences — Transforming Patient Care by Unlocking New Target Spaces March Biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity
Nectin Therapeutics — NectinTX is a biotech company focused on unlocking the power of the immune system by developing a collection of next-gen immunotherapy agents.

Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.

Investment focus

Information Technology, Health Care, Software
Seed, Series A, Funding Round
Israel, United States, China

Portfolio highlights

Creednz — B2B Payments Protection using internal finance data enriched w/ externally curated intelligence, enabling informed payment decisions in RT.
Entitle — Control access to your organizational cloud resources without creating bottlenecks or friction while creating a seamless experience for employees.
Tamnoon — Tamnoon develops a state-of-the-art cloud security platform to empower security teams and manage cloud risks effectively. By harnessing the power of AI combined with human expertise, the company empowers security teams and equips organizations of all sizes with exceptional cloud protection capabilities.

Morris Kahn bussiness in Aurum Ventures MKI and The Kahn Foundation an independent private philanthropic foundation.

Investment focus

Biotechnology, Medical Device, Information Technology
Seed, Series A, Series C
Israel

Portfolio highlights

Nucleix — OUR TESTS AIM TO DETECT CANCER EARLIER - WHEN TREATMENT CAN BE MOST EFFECTIVE FOR PATIENTS OUR PRODUCTS
Scopio Labs — Click here to learn more about Scopio Labs AI Driven Digital Platform for Cell Morphology.
KidneyCure — KidneyCure offers a novel dimension to treating advanced Chronic Kidney Disease.

HealthpointCapital, LLC is a values-based, research-driven private equity firm that is differentiated by its focus on the musculoskeletal industry. HealthpointCapital has over $800 million of assets under management, including co-investments, resulting in 24 corporate acquisitions for HealthpointCapital's seven platform businesses. The sevenplatform companies, Alphatec Spine, Inc., BioHorizons Implant Systems, Inc., Blue Belt Technologies, Inc., China Rehabilitation Ltd., MicroDental, Inc., Nexa Orthopedics, Inc. and OrthoAccel Technologies, Inc., represent outstanding platforms in some of the key high-growth segments of the orthopedic industry: Robotics, Spine, Dental, Extremities and Emerging Markets.

Investment focus

Medical, Biotechnology, Manufacturing
Series B, Series C, Funding Round
Israel, United States

Portfolio highlights

OrthoSpace — OrthoSpace develops and commercializes simple-to-implant, biodegradable balloon systems for the orthopaedic market. The company aims to create effective solutions for orthopaedics that reduce pain and increase patients’ range of motion while preserving patient bone and joint structures.The company’s first product has the CE mark and iscurrently marketed in Europe. InSpace™ is indicated for patients who suffer from rotator cuff injury, reducing shoulder pain and improving range of motion.
OrthoAccel Technologies — Straighten Your Smile Faster With AcceleDent SoftPulse Technology. Simple To Use, Allowing Braces To Feel More Comfortable With Only 20 Minutes Daily Use!

NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.Led by Omri Amirav Drory, a venture partner with NFX, who founded Genome Compiler, it helps scientists learn to be founders and guides biology companies with information technology to be a critical distinction with massiveimplications.

Investment focus

Biotechnology, Therapeutics, Medical
Seed
Israel

Portfolio highlights

resistanceBio — Identify the primary drivers of clinical trial success with ENCER cancer models.
Eleven Therapeutics — Harnessing the power of combinatorial chemistry and AI to transform RNAi drug development into a programmable process.
Pangea Therapeutics Ltd. — We are on a mission to redefine cancer care by combining disruptive molecular biology technology with state of the art bioinformatics and machine learning.

Minrav provides engineering and construction services.

Investment focus

Health Care, Hospital, Wellness
Funding Round
Israel, Malaysia

Portfolio highlights

iwi Life — Algae is the ultimate source of Omega-3s. Research has proven that Omega-3s support cardiovascular health, a balanced mood, and healthy brain development.
Qualitas Health — Qualitas Health Group aims to serve patients through a network of 500 clinics by 2022 with quality healthcare services across the Asia Pacific.

Since the firm was founded in 1994, Jerusalem Global's goal has been to support private Israeli technology initiatives and to generate superior returns to investors. Over the last two decades, the partners of Jerusalem Global Ventures have developed strong ties with the top Israeli entrepreneurs and visionaries enabling JGV to invest in thebest of Israel's entrepreneurs and help their portfolio companies build winning management teams.

Investment focus

Software, Information Technology, Biotechnology
Series A, Series B, Series C
United States, Israel, Canada

Portfolio highlights

Moovit — Utilizing the power of MaaS, we're helping cities, transit agencies and corporations simplify urban mobility, making it more efficient, accessible and sustainable.
Quiet Therapeutics — Quiet Therapeutics is an emerging biotech company founded in 2010 developing a proprietary nanoparticle-based delivery system (gagomers) focused on oncology and inflammation.Based on the targeting capability of our innovative technology, the company is well positioned to expand the drug target repertoire in cancer and inflammation. The Gagomerdelivery approach enables us to target cell components that are not manageable by other therapeutic agents like small molecules or antibodies.
SolarEdge Technologies — Turn your businesses and homes into a sustainable energy hub with a SolarEdge inverter solution and the SolarEdge energy manager platform.

The Chartered Group is an investment platform.

Investment focus

Biopharma, Agriculture, Health Care
Funding Round, Series A, Private Equity
Israel

Portfolio highlights

Zsquare — Zsquare has developed the only scalable endoscopic platform capable of transmitting high resolution images in flexible, single-use endoscopes, through polymeric fibers of any shape or size. Zsquare’s imaging technology outperforms existing technologies by delivering higher quality visualizations through smaller diameters than those found inreusable endoscopy systems.Zsquare’s polymeric fiber enables the housing of inexpensive optics with no electronics in a single-use shell, and expensive components in a detachable, reusable imaging core. This platform feature allows the use of a single core with various interchangeable shells which offer differing capabilities for different indications, facilitating any type of endoscopy procedure at a lower costs per-use.
Pepticom Ltd. — Pepticom is a privately held AI company with headquarters in Israel committed to offering AI peptide drug discovery solutions for a better and healthier world. It is the leader in the emerging peptide drugs software solutions, AI and prediction tools that allow research centers, pharma and agriculture companies to accelerate innovative moleculesdiscovery while reducing time, costs and risks. Pepticom operates in various markets; past successful discoveries include peptide molecules related to metabolic diseases and Immuno-modulators.

DSM Venturing provides start-up funding, coaching and support for start-up companies that share our purpose of creating brighter lives for all.

Investment focus

Biotechnology, Health Care, Manufacturing
Series A, Funding Round, Series B
United States, Canada, Israel

Portfolio highlights

Vivici — Our mission is to meet the world's growing need for sustainable, nutritious and great tasting animal-free proteins.
Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
Incredo — DouxMatok is a food-tech company. They have developed a proprietary technology that enhances the sweetness of sugars with no after taste - preserving the full "sugar experience" customers are looking for. The enhanced sweetness allows for a significant reduction in the consumption of sugar.The company was incorporated in 2014, and itsR&D center is based in Petach-Tikva, Israel.

RMGP Biopharma Investment Fund is an investment Fund

Investment focus

Biotechnology, Biopharma, Health Care
Seed, Series B, Funding Round
Israel

Portfolio highlights

Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.

NevaTeam Partners is an Agri-Food Tech ESG Impact driven Fund with world-class knowledge and expertise that specializes in identifying and investing in cutting-edge companies and technologies, contributing to the streamlining and increase in world food production in a sustainable way.

Investment focus

AgTech, SaaS, Farming
Seed, Series A
Israel

Portfolio highlights

Brevel — Brevel is leading the way with its breakthrough fermentation technology, offering delicious, affordable and sustainable protein.
Clarifruit — First automated fruit and vegetable fresh produce quality control software solution by Clarifruit. Optimize your fresh produce QC >>
Edete Precision Technologies for Agriculture — edete Precision Agriculture Technologies is solving the world’s ever-growing pollination challenge by developing and manufacturing an efficient, automated fruit orchard pollination system and providing optimized pollination services to companies and growers.By reducing the dependency on haphazard, insect-based pollination processes, edete’scontrolled and manageable mechanical pollination system improves the quantity and quality of fruit orchard yields.

Tyson Ventures is the investment arm of Tyson Foods. We aim to be the strategic partner of choice for disruptive innovators transforming the food industry, and provide sustainable nutrition to a growing global population. Our current areas of interest focus on emerging proteins, technology enablers and sustainability. Let’s build the future offood... together.

Investment focus

Food and Beverage, Organic Food, Biotechnology
Funding Round, Series B, Seed
United States, Israel

Portfolio highlights

Athian — Funding livestock sustainability via a connected carbon marketplace.
MycoTechnology — MycoTechnology is a food ingredient company focused on moving food forward by infusing human ingenuity with the intelligence of nature. Harnessing the power of mushrooms, MycoTechnology is able to solve some of the most pervasive challenges in the food and beverage industry.
Soft Robotics — Soft Robotics is an industry-leading technology company that designs and builds automated, high-speed picking solutions using proprietary soft robotic grippers, 3D machine vision, and artificial intelligence. The company's transformational robotic solutions enable system integrators and OEM machinery builders to offer solutions that automate some of the most challenging bulk processes found in food production.

Israeli Early Stage Deep Tech Fund

Investment focus

Information Technology, Software, Cyber Security
Seed, Pre-Seed, Series A
Israel

Portfolio highlights

Wib Security — Wib is the only way to secure your APIs from development to production, with the most comprehensive full-lifecycle API Security Platform.
Cydome — Cydome offers comprehensive maritime cybersecurity solutions for protecting IT and operational assets at sea, ensuring readiness for regulatory inspections.
Cyngular Security — Cyngular Security - Cloud Autonomous Hunting, Investigation and Response Platform Helps organizations proactively prepare for and respond to cyber security incidents, ensuring maximum protection and minimum downtime.

SCP Vitalife is a Life Sciences Fundformed by SCP Partners , a U.S.-based investment organization with over $900 million in venture funds under management, and Vitalife , an experienced venture firm investing primarily in Israeli medical technology companies. The SCP Vitalife team includes investment professionals with prior experiences as seniorexecutives, clinical practitioners and venture capitalists.Their focus is on early to mid-stage life science technologies and services, with a concentration on therapeutic medical devices.They will continue to follow the successful formula of their predecessor fund, Vitalife Life Sciences Fund, offering their portfolio companies hands-on strategic assistance in planning, operations and finance. From their investment experience they have developed extensive networks to access capital, recruit management and facilitate favorable strategic alliances.

Investment focus

Health Care, Medical, Medical Device
Series C, Series D, Funding Round
Israel, United States

Portfolio highlights

MST Medical Surgery Technologies — Medical Surgery Technologies (MST) was founded in 2005 by Ziv Tamir and Moti Sholev, entrepreneurs with extensive experience in medical devices. MST leads the field of surgical analytics with its core image analytics technology designed to empower and automate the surgical environment, with a focus on medical robotics and computer-assisted surgery(MRCAS). The company's core technology is a software-based image analytics information platform powered by advanced visualization, scene recognition, artificial intelligence, machine learning and data analytics. The platform is positioned to enable the operating room of the future through real-time image analytics, connectivity and automation, providing value-added functionality for surgeon, provider and patient. MST’s initial offering is AutoLap™, the only robotic image-guided laparoscope positioning system. Powered by MST’s image-analysis software, AutoLap™ interacts with the surgeon’s movements in the surgical cavity, guiding the robotic laparoscope positioner in real time, offering the surgeon full and natural control of the surgical procedure and an optimal field of view.
Ivenix — Ivenix, Inc. has transformed infusion delivery by designing an FDA cleared infusion system that sets new standards in usability, safety & interoperability.
Rewalk Robotics — ReWalk Robotics is a medical device company that designs and develops powered solutions that provide gait training and mobility for lower limb disabilities.

Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.

Investment focus

Manufacturing, Health Care, Natural Resources
Private Equity, Debt Financing, Funding Round
United States, Israel

Portfolio highlights

The Good Feet Store — Good Feet has been helping people with foot problems feel better and get back to living their lives. Personally fit with the arch support that meets their needs. Contact us now to see the available Good Feet Arch Support!
WESTCO GROUNDS — Westoco Provides Landscaping is a highly competitive industry, and Westco continues to thrive because it tailor services to specific client needs and deliver complete solutions with dependability,Rainbird facilitate quick responses and ressources.
Conditioned Air — Conditioned Air is South Florida's premier air conditioning contractor with 60 years of experience. Serving Naples, Venice, Ft. Myers, Englewood, Port Charlotte, Sarasota, Bradenton & Surrounding Areas.

BRM Capital is a dynamic venture capital fund investing in early stage, Israel-related software, internet infrastructure, and communication companies. Their investment focus is on the Internet, mobile and mobile applications, digital media, online services, enterprise software, and medical device sectors and they also offer flexible, streamlinedinvestment decision making.BRM headquartered in Tel Aviv, Israel enjoys a worldwide network of industry, strategic and financial experts.

Investment focus

Software, Information Technology, Internet
Series B, Funding Round, Series A
United States, Israel

Portfolio highlights

V-Wave — V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.
ShopperAI — ShopperAI is a company that provides AI-powered shopper research and analytics tools to understand customer behavior and grow the business.
Exceed Talent Capital — Exceed is an innovative platform to invest, earn, engage, influence, and celebrate Talent.

Chartered Opus offers professional market participants (clients such as asset managers) the opportunity to realise “securitised” concepts/products for their own investment or for their customers.

Investment focus

Wellness, Biotechnology, Manufacturing
Series A
Israel

Portfolio highlights

SolCold — We make the sun cool again - Solcold the new environment solutions
Trobix Bio — AN ENGINEERING PHAGE PLATFORM TO DELIVER UNIQUELY DESIGNED DNA CARGOS

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate